a 75% probability outcome is they announce data August 15-18. it's spun as super forward leaning "antiviral $44B market" opportunity. the share price pops to .37, and then retreats back to around .20 in 2-3 days. they announce they are applying for emergency use. a long wait of 60 days occurs into january 2022. they don't get emergency use approval. they say they are still hopeful in partnering, a grant, etc for a large phase 3 trial. we wait month after month for a grant or a partnership, as we hear more press releases on antiviral potential, and then the covid/antiviral play fades into obscurity and we have already heard more about a UC trial in late 2021, but it really starts in feburary 2022, and then we hear how massive that market opportunity is, results in 2023.
and the band played on.
a 10% probability outcome is the deliver the most amazing covid results on the face of the earth and get some fast partnering etc
that leaves us with what? 15% probability outcome of a total abject ph2 fail, where we still here that the antiviral market is huge and they will still try to get a grant or a partnership for other viruses we ain't never heard of.
just place your damn bets.
ipix tune is old and tiresome.
why are we at .20 in the greatest pandemic of all time---that actually is ending. for the pumpers, do you ever ask yourself why ipix failed to get a single grant dollar, or why if we have the cure to covid big pharma hasn't taken ipix out? or why the mainstream media is not talking about brilacidin? or why ipix hasn't released the 'other' antiviral data they keep mentioning? why? because we are smarter than everyone else? because ipix is smarter than big pharma and the global scientific community? smarter than the grant gifting committees? look around american cities and hopsitals...cities are beaming with life and hospitals are celebrating no covid patients on a daily basis.
and the band played on. the circus is leaving town.
the clowns are in wakefield or elsewhere?
News 
Market Data 
Discover 
AI
